Proto Labs, Inc.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US7437131094
USD
52.37
-0.35 (-0.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Proto Labs, Inc. stock-summary
stock-summary
Proto Labs, Inc.
Specialty Chemicals
Proto Labs, Inc. is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company's geographic segments include the United States, Europe and Japan. The Company targets its products to the product developers and engineers who use 3D computer-aided design (3D CAD) software to design products across a range of end markets. Its product lines include Injection Molding, CNC Machining and 3D Printing. Its Injection Molding product line is used for prototype, on-demand and short-run production. Its CNC Machining product line uses commercially available CNC machines to cut plastic or metal blocks into one or more custom parts. Its 3D Printing product line includes stereolithography (SL), selective laser sintering (SLS) and direct metal laser sintering (DMLS) processes. The Company also provides low-volume sheet metal fabrication services.
Company Coordinates stock-summary
Company Details
5540 Pioneer Creek Dr , MAPLE PLAIN MN : 55359-9003
stock-summary
Tel: 1 763 47974741 763 4797726
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 66 Schemes (46.45%)

Foreign Institutions

Held by 105 Foreign Institutions (11.18%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Sven Wehrwein
Independent Chairman of the Board
Ms. Victoria Holt
Director
Mr. Archie Black
Independent Director
Mr. Sujeet Chand
Independent Director
MS. Moonhie Chin
Independent Director
Dr. Rainer Gawlick
Independent Director
Mr. John Goodman
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
135 Million
(Quarterly Results - Jun 2025)
Net Profit:
4 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 1,200 Million (Small Cap)

stock-summary
P/E

44.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.15

stock-summary
Return on Equity

3.08%

stock-summary
Price to Book

1.80